Metformin bør ikke brukes av pasienter med nedsatt nyrefunksjon

Tidsskrift for den Norske Laegeforening

Volumn 128, Issue 8, 2008, Pages 936-937

  Gudmundsdottir, Helga ^a   Brørs, Odd ^a   Os, Ingrid ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METFORMIN;

ACUTE KIDNEY FAILURE; ARTICLE; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DRUG COMBINATION; DRUG CONTRAINDICATION; DRUG EFFECT; HUMAN; LACTIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

ACIDOSIS, LACTIC; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; METFORMIN; RENAL DIALYSIS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 43049128243     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (11)

1. Legemiddelforbruket i Norge. www.legemiddelforbruk.no (30.5.2007).
2. Gudmundsdottir H, Aksnes H, Heldal K, Krogh A, Froyshov S, Rudberg N et al. Metformin and antihypertensive therapy with drugs blocking the renin angiotensin system, a cause of concern? Clin Nephrol 2006; 66(5): 380-385.
3. Hanssen KF. Melkesyreacidose som bivirkning av metformin. Tidsskr Nor Laegeforen 2003; 123(18): 2583-2584.
4. Lovas K, Fadnes DJ, Dale A. Metforminassosiert laktacidose - pasienteksempel og litteraturgjennomgang. Tidsskr Nor Laegeforen 2000; 120(13): 1539-1541.
5. Norsk legemiddelhåndbok for helsepersonell 2007: 747. 2007.
6. Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH. Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med 2002; 162(4): 434-437.
7. Hartmann A, Holdaas H, Os I, Hunderi OH, Hallan S, Wideroe TE et al. Stadieinndeling og måling av nyrefunksjon ved kronisk nyresykdom. Tidsskr Nor Laegeforen 2006; 126(9): 1198-1200.
8. Klow NE, Draganov B, Os I. Metformin og røntgenkontrastmidler- økt risiko for lakacidose. Tidsskr Nor Laegeforen 2001; 121(15): 1829.
9. Chan NN, Fauvel NJ, Feher MD. Non-steroidal anti-inflammatory drugs and metformin: a cause for concern? Lancet 1998; 352(9123): 201.
10. Prikis M, Mesler EL, Hood VL, Weise WJ. When a friend can become an enemy! Recognition and management of metformin-associated lactic acidosis. Kidney Int 2007; 72(9): 1157-1160.
11. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 2003; 163 (21): 2594-2602.)